Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-10

Clinical Trial Update: Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism [NA]

View source ↗

Summary

A terminated clinical trial evaluated the efficacy and tolerability of ramelteon in patients with REM sleep behavior disorder and Parkinsonism, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

Sponsor: Northwestern University | Conditions: REM Behavior Disorder, Parkinsonism | NA | Status: TERMINATED | Results posted: 2010-11-10